Dr. Lillian Siu, MD
Claim this profilePrincess Margaret Cancer Centre
Studies Lung Cancer
Studies Melanoma
18 reported clinical trials
42 drugs studied
About Lillian Siu, MD
Education:
- Earned an MD (Doctor of Medicine) from the University of Toronto, Canada.
- Completed her residency in Medical Oncology at the University of Toronto.
Experience:
- Serves as a Senior Scientist at the Princess Margaret Cancer Centre, Toronto, Canada.
- Holds a position as Professor of Medicine at the University of Toronto.
- Acts as Co-Director of the Phase I Program at the Princess Margaret Cancer Centre.
- Is a Founding member and Chair of the Global Cancer Drug Development Forum.
- Recognized for significant contributions to cancer research and drug development.
Area of expertise
1Lung Cancer
Stage IV
MSI-H positive
TMB-H positive
2Melanoma
Stage IV
MSI-H positive
TMB-H positive
Affiliated Hospitals
Clinical Trials Lillian Siu, MD is currently running
SGN-PDL1V
for Cancer
This trial is testing a new drug, SGN-PDL1V, alone and with pembrolizumab, in patients with advanced solid tumors. The goal is to see if these treatments are safe and effective. SGN-PDL1V targets cancer cells directly, while pembrolizumab helps the immune system fight the cancer.
Recruiting1 award Phase 1
Targeted Cancer Drugs
for Cancer
Cancer drugs which target the effects of abnormal gene changes are called 'targeted therapies'. This study, called PM.1 or CAPTUR, will include some targeted therapies that are currently available. The purpose of this study is to find out what are the effects on a patient and their cancer when they are given a targeted therapy drug that is specific to an abnormal gene change in their cancer.
Recruiting1 award Phase 23 criteria
More about Lillian Siu, MD
Clinical Trial Related7 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Lillian Siu, MD has experience with
- Dostarlimab
- MET-4
- Trametinib
- Cetuximab
- Monalizumab
- Sym021
Breakdown of trials Lillian Siu, MD has run
Lung Cancer
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lillian Siu, MD specialize in?
Lillian Siu, MD focuses on Lung Cancer and Melanoma. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are MSI-H positive.
Is Lillian Siu, MD currently recruiting for clinical trials?
Yes, Lillian Siu, MD is currently recruiting for 11 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Lillian Siu, MD has studied deeply?
Yes, Lillian Siu, MD has studied treatments such as Dostarlimab, MET-4, Trametinib.
What is the best way to schedule an appointment with Lillian Siu, MD?
Apply for one of the trials that Lillian Siu, MD is conducting.
What is the office address of Lillian Siu, MD?
The office of Lillian Siu, MD is located at: Princess Margaret Cancer Centre, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the Princess Margaret Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.